Elizabeth Sharman Pharm.D., DABAT, BCPS, FAACT
Professor of Clinical Pharmacy
West Virginia Poison Center
Elizabeth J. Scharman, Pharm.D., DABAT, BCPS, FAACT has been the Director of the West Virginia Poison Center (WVPC) and a full-time faculty member with the West Virginia University (WVU) School of Pharmacy since July 1992. Dr. Scharman works out of the WVU Robert C. Byrd Health Sciences Center Charleston Division. She received tenure in 1998 and became a full Professor within the Department of Clinical Pharmacy in July 2003. Dr. Scharman received a B.S. in Pharmacy (1986) from Butler University and a Pharm.D. (1991) from Virginia Commonwealth University (Medical College of Virginia) then completed a Clinical Toxicology Fellowship (1992) at the Pittsburgh Poison Center affiliated with the University of Pittsburgh. She became a Diplomate of the American Board of Applied Toxicology (ABAT) in 1992 and a Board Certified Pharmacotherapy Specialist in 1995. Dr. Scharman has held numerous elected positions on boards of national organizations including the American Academy of Clinical Toxicology (AACT), the American Board of Applied Toxicology (in which she also served as President from 2004 to 2006), and the American Association of Poison Control Centers. She currently serves as a member and/or Chair of multiple of national committees; many of which are working to advance the accuracy and rigor of toxicosurveillance databases. In 2014, Dr. Scharman was appointed to the editorial board of the journal, Clinical Toxicology (Phila); she has been Chair of the Toxicology and Poison Control Editorial Panel for the journal, Annals of Pharmacotherapy, since 2003. Dr. Scharman teaches the clinical toxicology, disaster planning, and substance abuse related classes for the WVU School of Pharmacy in addition to content area related to adverse drug reactions. She also provides continuing education presentations for physicians, nurses, and pharmacists throughout WV on topics related to clinical toxicology and drugs of abuse. Dr. Scharman has multiple peer reviewed publications in the field of clinical toxicology and evidence-based practice.